Marketing-authorisation holder
Advanced Accelerator Applications
3 medicines in 1 country, as authorisation holder.
Group structure
Part of
AdvancedPharmaceutical groupOther companies in the group
Canada7
Spain3
Netherlands1
1 more country
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
3 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Lutathera | Lutetium(177 lu)oxodotreotide | EU (EMA) | Authorised | 2017 |
| LysaKare | Arginine, Lysine | EU (EMA) | Authorised | 2019 |
| SomaKit TOC | Gallium (68ga) edotreotide | EU (EMA) | Authorised | 2016 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| European Union (EMA) | 3 | 3 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- All other therapeutic productsVarious · ATC V03A
- Diagnostic radiopharmaceuticalsVarious · ATC V09I
- Therapeutic radiopharmaceuticalsVarious · ATC V10X
Top substances
The active substances in most of its medicines.
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
European Medicines Agency
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Group
- Advanced
- Medicines
- 3
- Countries
- 1
- Roles
- Authorisation holder